The electron spin resonance (ESR) spectrum of erythrocytes of a healthy male volunteer exhibited 2 min after intravenous administration of 1 g of ascorbic acid a considerable increase in spin concentration and a new signal at about g = 2.005 which we previously had found to correlate to the semidehydroascorbate (SDA) radical and which is not identical with the O j radical. Moreover, the vitamin C concentration in erythrocytes and plasma was considerably higher than in comparable samples of other volunteers treated identically. In the latter cases, the ESR spectrum of the erythrocytes was not modified at all. These findings suggest that there must be a substance which reacts with ascorbic acid specifically. It can be assumed that the enzyme ascorbate oxidase plays this decisive role in the ascorbic acid metabolism. For this reason, different amounts of ascorbate oxidase have been added to healthy erythrocytes treated in vitro with ascorbic acid and to tissue samples of lung cancer. As expected, the vitamin C effect as expressed by the appearance of the SDA signal and the increase in spin concentration could be reversed. It is suggested, therefore, that in special types of cancer, such as acute lymphatic leukemia and lung cancer, the concentration of ascorbate oxidase or of an enzyme acting like it is, primarily, diminished, while in other types it might be enlarged.
Introduction
Recently we succeeded in identifying the electron spin resonance (ESR) signal at about g = 2.005 which is present in lyophilized native blood and its con stituents o f patients with acute lym phatic leukemia [1 -4 ] . We could dem onstrate that it is due to the sem idehydroascorbate (SDA) radical. In in vivo experiments, in which 1 g o f ascorbic acid was adm inistered intravenously to healthy volunteers, the ESR spectrum o f native blood is identical to that obtained in the case o f acute lym phatic leuke m ia [5] . W hile it prevails in untreated leukemic patients, it returns to normal within several hours to one day in these healthy volunteers. From these results and previous findings [2, 3] one might conclude that a substance which reacts with ascor bic acid specifically exists in healthy individuals regulating the interaction between vitam in C and blood constituents, but which is present in patients with acute lym phatic leukem ia only in a dim inished quantity.
There were some indications that ascorbate oxid ase or an enzyme acting similarly might be the sub stance in question. Therefore, the effect o f ascorbate oxidase on erythrocytes treated with ascorbic acid and on cancerous lung tissue has been investigated Reprint requests to Prof. Dr. W. Lohmann. 0341-0382/81/0900-0804 $01.00/0 by means o f ESR spectroscopy, in order to elucidate its molecular mechanism of interaction. Norm al erythrocytes treated with ascorbic acid were used as a model since their ESR signal is identical to that obtained in the cases of acute lymphatic leukem ia 
Materials and Methods
Erythrocytes were obtained from fresh 1:10 ACD-blood (acid-citrate-dextrose anticoagulant solution) o f healthy volunteers and prepared ac cording to a m ethod described previously [2] . As corbate oxidase from C ucurbita species (L-Ascorbate: oxygen oxidoreductase, EC 1.10.3.3; Boehringer, M annheim, Germ any) was added in different concentrations (up to 20 000 U) to 0.2 ml of erythro cytes treated prior with either 0.5 or 1.0 mM of ascorbic acid (Merck, D arm stadt, Germany). T here after, the samples were lyophilized and their ESR spectra m easured at room tem perature.
The ESR spectra were obtained with a Varian E-9, 100-kHz m odulation X -band spectrometer. A DPPH (diphenylpicrylhydrazil) standard (g = 2.0036) was used as a reference for marking reso nance positions. The m odulation am plitude was g 0.2 mT and the microwave power 5 mW for all samples investigated. The spectra of 50 mg samples each were recorded at different sensitivities marked at the left-hand side o f each spectrum. The relative spin concentration was obtained by double inte gration of the spectra by means o f a planim eter.
In one case, 5 ml o f a solution containing 1 g o f ascorbic acid (Merck, D arm stadt, G erm any) have been adm inistered intravenously to a 26 year old healthy male volunteer. Shortly before and 2, 5, 15, 60 min, 4, 24, and 48 h after the adm inistration, 0.5 ml of native blood and 10 ml o f 1:10 A C D -blood were collected. The latter samples were used for separation of erythrocytes and plasma. All were subsequently lyophilized for the ESR studies. Two ml of EDTA-blood were obtained sim ultaneously for the hematologic examinations.
The concentration o f ascorbic acid in erythrocytes and plasma was determ ined after derivatization with 2,4-dinitrophenylhydrazine according to the method described by Omaye et al. [6] .
In order to test the effect o f ascorbate oxidase on cancerous lung tissue, 5 g samples were soaked with 0.2 ml of an aqueous solution containing 10000 U o f the enzyme im m ediately following surgical removal. Obviously, such an experim ent will only provide qualitative data; it might be, however, indicative for the action o f this enzyme.
Results
Recently we have shown that 1 g o f ascorbic acid, administered intravenously to young healthy volun teers, didn't affect the ESR spectrum o f erythrocytes while that of native blood was m odified in shape and spin concentration as well [5] . Furtherm ore, ascorbic acid concentration was found to be un changed in erythrocytes, while it showed an initial increase in plasma. This result could be confirm ed in additional experiments with the exception of one case. Here, also the ESR spectrum o f the erythrocytes exhibited an increase in spin concen tration and the SDA signal located at about g = 2.005 two minutes after ascorbic acid adm inistration (s. Fig. 1) . Concomitantly, only im m ediately after injection a drastic increase in ascorbic acid concen tration could be observed in erythrocytes and plasma (about 3.5 times of the increase observed in other volunteers after injection of 1 g of ascorbic acid). However, five and more m inutes after ad ministration of ascorbic acid all o f the values were com parable to those obtained with the other volun teers [5] . From this, it might be concluded that in this individual, after the injection of ascorbic acid, there might be a shortlasting break-down (for a few minutes only) of the system regulating the ascorbic acid metabolism which results in an additional release of vitamin C from an unidentified pool. Im mediately thereafter the complete system seems to function normally indicated by the same time response in spin-and vitamin C-concentration as observed in the other volunteers [5] . These findings suggest that there might be an enzyme which regulates the vitam in C metabolism and m aintains its concentration at an optim um value. There are (Fig. 2 a) or 1.0 m M of ascorbic acid (Fig. 2 b) . s £ rel. sensi tivities.
certain indications that this enzyme, using ascorbic acid as a substrate, is ascorbate oxidase or an enzyme acting similarly.
In order to verify this hypothesis, different am ounts of ascorbate oxidase have been added to 0.2 ml of healthy erythrocytes treated in vitro with either 0.5 m M or 1.0 m M o f ascorbic acid (Figs. 2 a  and b) . W ith increasing concentration o f the enzyme the spin concentration as well as the SDA peak decrease, as seen in the middle spectra of both Figures. W hile an interm ediate state can be seen in Fig. 2 b, lower curve, a return to the original state can be observed after the addition o f 20000 U o f ascorbate oxidase to 0.2 ml of erythrocytes treated with 0.5 m M o f ascorbic acid (Fig. 2 a, compare upper and lower curve). Addition o f this concen tration o f the enzyme to erythrocytes only has almost no effect at all on the spectrum.
In a prelim inary study the effect o f ascorbate oxidase on cancerous lung tissue has also been in-
sample.
vestigated. Immediately following surgical removal, 5 g of such a tissue have been soaked in 0.2 ml of an aqueous solution containing 10000 U of the en zyme. This qualitative study shows (Fig. 3 ) that this concentration of ascorbate oxidase diminishes the SDA peak considerably. As a m atter o f fact, this concentration is already too high comparing this spectrum with that of healthy tissue (see lower spectrum).
Discussion
From the results obtained the following con clusions might be drawn: In a few types o f cancer, e.g. acute lym phatic leukem ia and lung tum or, the ESR spectra exhibit the semidehydroascorbate radical and a characteristic change in spin concen tration. This effect can be also obtained if ascorbic acid is added to healthy tissue. Ascorbate oxidase reverses this effect and reestablishes ESR spectra as obtained with healthy tissue depending, of course, on the concentration used. Therefore, it seems very likely, that in these two types of cancer -and in all the ones, in which an increased ascorbic acid con centration can be measured -the concentration of ascorbate oxidase or of an enzyme which acts like it is, primarily, dim inished. This results in a rather uncontrolled rise of the concentration o f ascorbic acid and, thus, leads to an increased interaction with its receptors (probably C u2+-proteins). Such an interaction will result in the formation o f the sem i dehydroascorbate radical which, in turn, will cause lipid peroxidation [7] [8] [9] .
If ascorbate oxidase is a regulatory enzyme of the type discussed above, then it should also be re sponsible for the compensation of the effect pro duced in healthy volunteers after i.v. adm inistration o f ascorbic acid [5] . This suggests very strongly its existence in living systems. It has been detected in and extracted from plants; its existence in hum ans is still unknown. W ithin the blood system this enzyme ought to be located in the erythrocytes, since no SDA signal could be observed in such a sample of volunteers who had been injected intravenously with 1 g of vitam in C [5] . In the one case described above, these erythrocytes seem to have a reduced concentration of ascorbate oxidase or of a com par able enzyme.
If this mechanism is correct, then, there should be cases in which the opposite effect occurs. There should be some types of malignancies in which prim arily the concentration of ascorbate oxidase or of a comparable enzyme is increased and, thus, the ascorbic acid concentration decreased [10] . In a few cases of acute myeloic leukem ia studied thus far, the SDA signal could never be observed and the ascorbic acid concentration was too low com pared with the controls.
Finally, it should be pointed out that the signal located at g = 2.005 is not identical with the O 7 radical.
